Clover Health To Report Fourth Quarter And Full Year 2025 Financial Results On February 26, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Alignment Healthcare and its peers.

Upfront premiums collected by health insurers lead to reliable revenue, but profitability ultimately depends on accurate risk assessments and the ability to control medical costs. Health insurers are also highly sensitive to regulatory changes and economic conditions such as unemployment. Going forward, the industry faces tailwinds from an aging population, increasing demand for personalized healthcare services, and advancements in data analytics to improve cost management. However, continued regulatory scrutiny on pricing practices, the potential for government-led reforms such as expanded public healthcare options, and inflation in medical costs could add volatility to margins. One big debate among investors is the long-term impact of AI and whether it will help underwriting, fraud detection, and claims processing or whether it may wade into ethical grey areas like reinforcing biases and widening disparities in medical care.

The 12 health insurance providers stocks we track reported a strong Q3. As a group, revenues beat analysts’ consensus estimates by 2.3% while next quarter’s revenue guidance was 1.4% below.

While some health insurance providers stocks have fared somewhat better than others, they have collectively declined. On average, share prices are down 2.7% since the latest earnings results.

Alignment Healthcare

Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination.

Alignment Healthcare reported revenues of $993.7 million, up 43.5% year on year. This print exceeded analysts’ expectations by 1.2%. Overall, it was a strong quarter for the company with a beat of analysts’ EPS estimates and full-year EBITDA guidance exceeding analysts’ expectations.

“Our third quarter results mark the third consecutive quarter in which we surpassed the high end of our guidance across all key metrics,” said John Kao, founder and CEO.

Interestingly, the stock is up 29.7% since reporting and currently trades at $22.20.

Read why we think that Alignment Healthcare is one of the best health insurance providers stocks, our full report is free.

Best Q3: CVS Health

With over 9,000 retail pharmacy locations serving as neighborhood health destinations across America, CVS Health operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance through its Aetna subsidiary.

CVS Health reported revenues of $102.9 billion, up 7.8% year on year, outperforming analysts’ expectations by 4.1%. The business had an exceptional quarter with an impressive beat of analysts’ same-store sales estimates and a solid beat of analysts’ revenue estimates.

Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 11.8% since reporting. It currently trades at $72.50.

Weakest Q3: Molina Healthcare

Founded in 1980 as a provider for underserved communities in Southern California, Molina Healthcare provides managed healthcare services primarily to low-income individuals through Medicaid, Medicare, and Marketplace insurance programs across 21 states.

Molina Healthcare reported revenues of $11.48 billion, up 11% year on year, exceeding analysts’ expectations by 4.6%. Still, it was a slower quarter as it posted a significant miss of analysts’ full-year EPS guidance estimates and a significant miss of analysts’ EPS guidance for next quarter estimates.

As expected, the stock is down 5.8% since the results and currently trades at $183.73.

Read our full analysis of Molina Healthcare’s results here.

Clover Health

Founded in 2014 to improve healthcare for America's seniors through technology, Clover Health provides Medicare Advantage plans for seniors with a focus on affordable care and uses its proprietary Clover Assistant software to help physicians manage patient care.

Clover Health reported revenues of $496.7 million, up 50.1% year on year. This print topped analysts’ expectations by 5.4%. Taking a step back, it was a mixed quarter as it also recorded an impressive beat of analysts’ revenue estimates but full-year EBITDA guidance missing analysts’ expectations significantly.

Clover Health delivered the biggest analyst estimates beat and fastest revenue growth among its peers. The company added 2,903 customers to reach a total of 109,226. The stock is down 31.5% since reporting and currently trades at $2.41.

Read our full, actionable report on Clover Health here, it’s free.

Elevance Health

Formerly known as Anthem until its 2022 rebranding, Elevance Health is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.

Elevance Health reported revenues of $50.09 billion, up 12% year on year. This result beat analysts’ expectations by 1.2%. It was a strong quarter as it also recorded a beat of analysts’ EPS and revenue estimates.

The company lost 252,000 customers and ended up with a total of 45.37 million. The stock is down 9.7% since reporting and currently trades at $319.90.

Read our full, actionable report on Elevance Health here, it’s free.

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast to the S&P 500’s 8.2% gain. This may have investors wondering how to approach the situation.

Following the pullback, is now the time to buy CLOV? Find out in our full research report, it’s free.

Why Does CLOV Stock Spark Debate?

Founded in 2014 to improve healthcare for America's seniors through technology, Clover Health provides Medicare Advantage plans for seniors with a focus on affordable care and uses its proprietary Clover Assistant software to help physicians manage patient care.

Two Things to Like:

1. New Clients Drives Additional Growth Opportunities

Revenue growth can be broken down into the number of customers and the average spend per customer. Both are important because an increasing customer base leads to more upselling opportunities while the revenue per customer shows how successful a company was in executing its upselling strategy.

Clover Health’s total customers punched in at 109,226 in the latest quarter, and over the last two years, their count averaged 10.3% year-on-year growth. This performance was solid, reflecting its ability to "land" new contracts and potentially "expand" them later - a powerful one-two punch for sales.

2. Increasing Free Cash Flow Margin Juices Financials

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Clover Health’s margin expanded by 16.9 percentage points over the last five years. Clover Health’s free cash flow margin for the trailing 12 months was negative 4.9%, and continued increases could help it achieve long-term cash profitability.

One Reason to be Careful:

Revenue Tumbling Downwards

We at StockStory place the most emphasis on long-term growth, but within healthcare, a stretched historical view may miss recent innovations or disruptive industry trends. Clover Health’s recent performance marks a sharp pivot from its five-year trend as its revenue has shown annualized declines of 2% over the last two years.

Final Judgment